Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers

av Jain, Natasha A, Zhao, Songzhu, Wei, Lai, Rogers, Kerry A, Otterson, Gregory A, Wang, Tzu-Fei, Owen, Dwight H
I publikationen Cancer Manag Res (2020)

Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib

av Shenoi, Daniel P., Andritsos, Leslie A., Blachly, James S., Rogers, Kerry A., Moran, Mollie E., Anghelina, Mirela, Jones, Jeffrey A., Grever, Michael R.
I publikationen Blood Adv (2019)

Venous and Arterial Thrombosis in Patients with Haematological Malignancy During Treatment with Ibrutinib

av Kander, Elizabeth M, Zhao, Qiuhong, Bhat, Seema A, Hirsch, Jessica, Byrd, John C, Ooka, Lauren, Wiczer, Tracy, Woyach, Jennifer A, Awan, Farrukh T, Rogers, Kerry A, Wang, Tzu-Fei
I publikationen Br J Haematol (2019)

Hypertension and incident cardiovascular events following ibrutinib initiation

av Dickerson, Tyler, Wiczer, Tracy, Waller, Allyson, Philippon, Jennifer, Porter, Kyle, Haddad, Devin, Guha, Avirup, Rogers, Kerry A., Bhat, Seema, Byrd, John C., Woyach, Jennifer A., Awan, Farrukh, Addison, Daniel
I publikationen Blood (2019)

Early intervention with lenalidomide in patients with high-risk chronic lymphocytic leukemia

av Thangavadivel, Shanmugapriya, Zhao, Qiuhong, Epperla, Narendranath, Rike, Lindsey, Mo, Xiaokui, Badawi, Mohamed, Bystry, Darlene M., Phelps, Mitch A., Andritsos, Leslie A., Rogers, Kerry A., Jones, Jeffrey, Woyach, Jennifer A., Byrd, John C., Awan, Farrukh T.
I publikationen Clin Cancer Res (2020)

Incidence and Description of Autoimmune Cytopenias During Treatment with Ibrutinib for Chronic Lymphocytic Leukemia Autoimmune Cytopenias During Ibrutinib Treatment

av Rogers, Kerry A., Ruppert, Amy S., Bingman, Anissa, Andritsos, Leslie A., Awan, Farrukh T., Blum, Kristie A., Flynn, Joseph M., Jaglowski, Samantha M., Lozanski, Gerard, Maddocks, Kami J., Byrd, John C., Woyach, Jennifer A., Jones, Jeffrey A.
I publikationen Leukemia (2015)

Second Cancer Incidence in CLL Patients Receiving BTK Inhibitors

av Bond, David A, Huang, Ying, Fisher, James L, Ruppert, Amy S, Owen, Dwight H, Bertino, Erin M, Rogers, Kerry A, Bhat, Seema A, Grever, Michael R, Jaglowski, Samantha M, Maddocks, Kami J, Byrd, John C, Woyach, Jennifer A
I publikationen Leukemia (2020)

Incidence of Opportunistic Infections During Ibrutinib Treatment for B-cell Malignancies

av Rogers, Kerry A, Mousa, Luay, Zhao, Qiuhong, Bhat, Seema A, Byrd, John C, Boghdadly, Zeinab El, Guerrero, Tomas, Levine, Lauren B, Lucas, Fabienne, Shindiapina, Polina, Sigmund, Audrey M, Sullivan, Matthew, Wiczer, Tracy E, Woyach, Jennifer A, Awan, Farrukh T
I publikationen Leukemia (2019)

Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia

av Rogers, Kerry A., Huang, Ying, Ruppert, Amy S., Awan, Farrukh T., Heerema, Nyla A., Hoffman, Corinne, Lozanski, Gerard, Maddocks, Kami J., Moran, Mollie E., Reid, Mark A., Lucas, Margaret, Woyach, Jennifer A., Whitlow, W. Thomas, Jones, Jeffrey A., Byrd, John C.
I publikationen Blood (2018)

Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations

av Lucas, Fabienne, Larkin, Karylin, Gregory, C. Thomas, Orwick, Shelley, Doong, Tzyy-Jye, Lozanski, Arletta, Lozanski, Gerard, Misra, Shrilekha, Ngankeu, Apollinaire, Ozer, Hatice Gulcin, Sampath, Deepa, Thangavadivel, Shanmugapriya, Yilmaz, Selen A., Rogers, Kerry A., Byrd, John C., Woyach, Jennifer A., Blachly, James S.
I publikationen Blood (2020)

LC-FACSeq is a method for detecting rare clones in leukemia

av Hu, Eileen Y., Blachly, James S., Saygin, Caner, Ozer, Hatice G., Workman, Stephanie E., Lozanski, Arletta, Doong, Tzyy-Jye, Chiang, Chi-Ling, Bhat, Seema, Rogers, Kerry A., Woyach, Jennifer A., Coombes, Kevin R., Jones, Daniel, Muthusamy, Natarajan, Lozanski, Gerard, Byrd, John C.
I publikationen JCI Insight (2020)

Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists

av Koenig, Kristin L., Huang, Ying, Dotson, Emily K., Sheredy, Shane, Bhat, Seema A., Byrd, John C., Desmond, Emily, Ford, Jill, Iarocci, Shauna, Jones, Jeffrey A., Lucas, Margaret S., Moran, Mollie E., Wiczer, Tracy E., Woyach, Jennifer A., Awan, Farrukh T., Rogers, Kerry A.
I publikationen Blood Adv (2020)

Trametinib for the Treatment of IGHV4–34, MAP2K1 Mutant Variant Hairy Cell Leukemia

av Andritsos, Leslie A., Grieselhuber, Nicole R., Anghelina, Mirela, Rogers, Kerry A., Roychowdhury, Sameek, Reeser, Julie W., Timmers, Cynthia D., Freud, Aharon G., Blachly, James S., Lucas, David M., Lozanski, Gerard, Jones, Jeffrey A., Williams, Katie, Oakes, Christopher, Jones, Dan, Grever, Michael R.
I publikationen Leuk Lymphoma (2017)

Acalabrutinib plus Obinutuzumab in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia

av Woyach, Jennifer A., Blachly, James S., Rogers, Kerry A., Bhat, Seema A., Jianfar, Mojgan, Lozanski, Gerard, Weiss, David M., Andersen, Barbara L., Gulrajani, Michael, Frigault, Melanie M., Hamdy, Ahmed, Izumi, Raquel, Munugalavadla, Veerendra, Quah, Cheng, Wang, Min-Hui, Byrd, John C.
I publikationen Cancer Discov (2020)

Eμ-TCL1xMyc: a novel mouse model for concurrent CLL and B-cell lymphoma

av Lucas, Fabienne, Rogers, Kerry A., Harrington, Bonnie K., Pan, Alexander, Yu, Lianbo, Breitbach, Justin, Bundschuh, Ralf, Goettl, Virginia M., Hing, Zachary A., Kanga, Parviz, Mantel, Rose, Sampath, Deepa, Smith, Lisa L., Wasmuth, Ronni, White, Danielle K., Yan, Pearlly, Byrd, John C., Lapalombella, Rosa, Woyach, Jennifer A.
I publikationen Clin Cancer Res (2019)

Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib

av McWilliams, Emily M., Lucas, Christopher R., Chen, Timothy, Harrington, Bonnie K., Wasmuth, Ronni, Campbell, Amanda, Rogers, Kerry A., Cheney, Carolyn M., Mo, Xiaokui, Andritsos, Leslie A., Awan, Farrukh T., Woyach, Jennifer, Carson, William E., Butchar, Jonathan, Tridandapani, Susheela, Hertlein, Erin, Castro, Carlos E., Muthusamy, Natarajan, Byrd, John C.
I publikationen Blood Adv (2019)

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia

av Rogers, Kerry A., Huang, Ying, Ruppert, Amy S., Abruzzo, Lynne V., Andersen, Barbara L., Awan, Farrukh T., Bhat, Seema A., Dean, Allison, Lucas, Margaret, Banks, Christin, Grantier, Cara, Heerema, Nyla A., Lozanski, Gerard, Maddocks, Kami J., Valentine, Thomas R., Weiss, David M., Jones, Jeffrey A., Woyach, Jennifer A., Byrd, John C.
I publikationen J Clin Oncol (2020)

Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome

av Kittai, Adam S., Bond, David A., William, Basem, Saad, Ayman, Penza, Sam, Efebera, Yvonne, Larkin, Karilyn, Wall, Sarah A., Choe, Hannah K., Bhatnagar, Bhavana, Vasu, Sumithira, Brammer, Jonathan, Shindiapina, Polina, Long, Meixiao, Mims, Alice, O’Donnell, Lynn, Bhat, Seema A., Rogers, Kerry A., Woyach, Jennifer A., Byrd, John C., Jaglowski, Samantha M.
I publikationen Blood Adv (2020)

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

av Flinn, Ian W., Gribben, John G., Dyer, Martin J. S., Wierda, William, Maris, Michael B., Furman, Richard R., Hillmen, Peter, Rogers, Kerry A., Iyer, Swaminathan Padmanabhan, Quillet-Mary, Anne, Ysebaert, Loic, Walter, Harriet S., Verdugo, Maria, Klein, Christian, Huang, Huang, Jiang, Yanwen, Lozanski, Gerard, Pignataro, Daniela Soriano, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J.
I publikationen Blood (2019)

The BTK Inhibitor ARQ 531 Targets Ibrutinib Resistant CLL and Richter’s Transformation

av Reiff, Sean D., Mantel, Rose, Smith, Lisa L., Greene, JT, Muhowski, Elizabeth M., Fabian, Catherine A., Goettl, Virginia M., Tran, Minh, Harrington, Bonnie K., Rogers, Kerry A., Awan, Farrukh T., Maddocks, Kami, Andritsos, Leslie, Lehman, Amy M., Sampath, Deepa, Lapalombella, Rosa, Eathiraj, Sudharshan, Abbadessa, Giovanni, Schwartz, Brian, Johnson, Amy J., Byrd, John C., Woyach, Jennifer A.
I publikationen Cancer Discov (2018)